Primary care provider attitudes, experiences and practices about cannabidiol (CBD) and barriers to patient-provider communication about CBD use: A qualitative study

Sharma, Pravesh; Holland, Ashley; Sheikh, Taharat; Novy, Blake; Oesterle, Tyler S.; Platt, Rheanna; Hammond, Christopher J

doi:10.1016/j.pecinn.2022.100044

Cited by 10 publications

(4 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients' fear of being judged by their HCPs due to their personal beliefs on CBD and social stigma related to CBD use were also barriers reported in a study by Sharma et al 39 .…”

Section: Discussionmentioning

confidence: 76%

“…HCPs were not so knowledgeable about certain aspects on CBD. There is a need for increased research, awareness, education and training about cannabis and CBD to HCPs and students 1,[39][40][41][42][43][44][45][46][47] . Increased research, knowledge and availability of prescribing information and guidelines related CBD use might lead to an increased willingness of HCPs to recommend…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Knowledge and perceptions about Cannabidiol use

Calleja,

Szijj,

Serracino-Inglott

et al. 2024

J. Drug Delivery Ther.

View full text Add to dashboard Cite

Background: Cannabidiol (CBD) is one of the main cannabinoids present in the cannabis plant. The demand for CBD grew over time with more individuals consuming CBD products due to its potential therapeutic properties. Objectives: To assess the knowledge and perceptions of Maltese members of the public and health care professionals (HCPs) about CBD, one of the main cannabinoids present in the cannabis plant. Methods: Surveys aiming to assess the knowledge and perception of the public and HCPs about CBD were developed, validated and disseminated. Results: Four hundred members of the public and 150 HCPs completed questionnaires. Ninety-six percent of participants (n=384) agreed that CBD has a therapeutic effect. Respondents from the general public were mostly knowledgeable about CBD and its use, had positive perceptions in relation to CBD and like HCPs, feel more comfortable if CBD is recommended by HCPs. HCPs were not so knowledgeable about certain aspects on CBD. One hundred and twelve HCPs were not aware that there is only one FDA/EMA approved CBD-based product. HCPs would feel comfortable in prescribing CBD products for pain and insomnia and the majority of them (55%; n=83) believe that CBD has mostly an analgesic effect. Social stigma associated with the use of CBD and potential judgement of HCPs were barriers to CBD use. Conclusion: Increased research, knowledge and availability of prescribing information and guidelines related CBD use might lead to an increased willingness of HCPs to recommend CBD and lead to a decrease in potential barriers associated with its use. Keywords: Cannabidiol, positive perceptions, pain and insomnia

show abstract

“…Patients' fear of being judged by their HCPs due to their personal beliefs on CBD and social stigma related to CBD use were also barriers reported in a study by Sharma et al 39 .…”

Section: Discussionmentioning

confidence: 76%

Section: Discussionmentioning

confidence: 99%

Knowledge and perceptions about Cannabidiol use

Calleja,

Szijj,

Serracino-Inglott

et al. 2024

J. Drug Delivery Ther.

View full text Add to dashboard Cite

show abstract

“…There are many factors that may contribute to this gap in communication between patient and provider. Healthcare providers often lack knowledge about CBD and struggle to provide medical guidance to patients who are either already using CBD or considering its use [ 30 , 31 ]. Additionally, the lack of medical guidelines on CBD, limited time during appointments, or belief that the patient would avoid disclosing CBD use, may prevent physicians from opening a dialogue with patients about the substance [ 31 ].…”

Section: Discussionmentioning

confidence: 99%

Use and perceptions of Cannabidiol among individuals in treatment for opioid use disorder

Kudrich,

Chen,

Meng

et al. 2024

Harm Reduct J

View full text Add to dashboard Cite

Background Cannabidiol (CBD) is a widely available cannabis product with many claims as to potential health benefits including alleviating symptoms related to opioid use disorder (OUD). However, little is known as to how individuals with OUD perceive CBD, to what extent they may already be using CBD, and for what purposes. Methods A survey was conducted among individuals receiving treatment for OUD at the Addiction Institute of Mount Sinai in New York City from July 2021 to August 2023. The survey consisted of demographic questions, questions about opioid use, CBD use, and perceptions regarding CBD. Statistical analysis using ordinal logistic regression was employed to compare perceptions between CBD users and non-users while adjusting for age and race. Results Among 587 respondents, 550 completed the survey. Among all survey completers, 129 (23%) reported a history of using CBD for a variety of reasons including: anxiety (81, 62.8%), pain (65, 50.4%), sleep (63, 48.8%), depression (62, 48.1%), recreational purposes (32, 24.8%), or for other reasons (8, 6.2%). Of note, 22 (17.1%) respondents reported using CBD to control their addiction and 54 (41.9%) reported using CBD to ease opioid withdrawal symptoms. CBD users demonstrated more positive perceptions regarding its legality (β = 0.673, OR = 1.960, 95% CI [1.211, 3.176], p = .006), social acceptance (β = 0.718, OR = 2.051, 95% CI [1.257, 3.341], p = .004), and therapeutic potential compared to non-users. CBD users also had a more positive view of its potential future role in managing addiction (β = 0.613, OR = 1.846, 95% CI [1.181, 2.887], p = .007). Conclusions This study highlights a significant association between CBD usage and progressive views regarding CBD among individuals with OUD, suggesting a growing interest in CBD as a potential adjunctive therapy for individuals in substance use treatment. Some patients are already using CBD for anxiety, pain, sleep, depression, or as a harm reduction intervention to control their addiction or for opioid withdrawal symptoms. These findings underscore the importance of integrating patient perspectives into future research and treatment strategies involving CBD in the context of OUD.

show abstract

“…The sample of students included medical, pharmacy, and health science students. Both questionnaires were developed by the researcher and were based on a literature review of this particular topic [ 10 , 12 , 28 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 ].…”

Section: Methodsmentioning

confidence: 99%

Knowledge and Attitudes of Cannabidiol in Croatia among Students, Physicians, and Pharmacists

Batinic,

Curkovic,

Bukic

et al. 2023

Pharmacy

View full text Add to dashboard Cite

Due to cannabidiol’s health benefits and absence of serious side effects, its use is constantly growing. This is a survey-based cross-sectional study that was conducted to determine Croatian pharmacists’, physicians’, and students’ knowledge and attitudes about cannabidiol (CBD). Two questionnaires were created, one for students and the other for physicians and pharmacists. Our participants (in total 874: 473 students and 401 physicians and pharmacists) generally had positive attitudes towards CBD therapy as approximately 60% of them believe that CBD treatment is generally efficacious. Participants had positive attitudes toward the therapeutic value of CBD, especially pharmacists and pharmacy students (63.8% and 72.2%, respectively). Pharmacists were significantly more convinced that CBD could reduce the use of opioids prescribed for chronic pain (p < 0.05). Only 17.5% of students had read scientific papers about CBD, compared to a significantly higher percentage of physicians and pharmacists (43.0% and 47.8%, respectively) (p < 0.05). This study revealed a gap in knowledge regarding CBD, since 89.3% of pharmacists and physicians, as well as 84.8% of students, believe they need more education about CBD. We conclude that it is important to improve the educational curricula so that medical professionals can recommend CBD use to their patients when needed.

show abstract

Primary care provider attitudes, experiences and practices about cannabidiol (CBD) and barriers to patient-provider communication about CBD use: A qualitative study

Cited by 10 publications

References 28 publications

Knowledge and perceptions about Cannabidiol use

Knowledge and perceptions about Cannabidiol use

Use and perceptions of Cannabidiol among individuals in treatment for opioid use disorder

Knowledge and Attitudes of Cannabidiol in Croatia among Students, Physicians, and Pharmacists

Contact Info

Product

Resources

About